Protalix BioTherapeutics, Inc. Stock TEL AVIV STOCK EXCHANGE
Stocks
PLX
US74365A3095
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 732.50 ILa | -.--% |
|
+3.29% | +69.68% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 193M 0 170M 158M 145M 273M 18.54B 276M 1.88B 735M 9.16B 726M 710M 31.65B | P/E 2026 * |
12.3x | P/E 2027 * | 48x |
|---|---|---|---|---|---|
| Enterprise Value | 193M 0 170M 158M 145M 273M 18.54B 276M 1.88B 735M 9.16B 726M 710M 31.65B | EV / Sales 2026 * |
2.47x | EV / Sales 2027 * | 2.86x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protalix BioTherapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 30/06/2019 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 24/08/2025 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 01/07/2008 |
Aharon Schwartz
BRD | Director/Board Member | 82 | 01/11/2014 |
Dror Bashan
BRD | Director/Board Member | 59 | 30/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +3.29% | - | - | 193M | |
| +0.13% | +4.41% | +47.35% | +163.20% | 1,068B | |
| +0.97% | +6.88% | +58.02% | +53.12% | 641B | |
| -0.94% | +1.39% | +35.02% | +72.60% | 454B | |
| +0.15% | +8.03% | +38.37% | +33.85% | 351B | |
| +0.16% | +2.42% | +37.75% | +42.47% | 299B | |
| -1.13% | +1.81% | +17.87% | +15.01% | 266B | |
| +0.50% | +1.23% | -27.29% | -37.92% | 220B | |
| +0.06% | +3.32% | +22.73% | +59.40% | 203B | |
| +0.94% | -2.02% | +12.32% | +70.59% | 162B | |
| Average | +0.09% | +2.76% | +26.91% | +52.48% | 407.04B | |
| Weighted average by Cap. | +0.11% | +2.85% | +36.51% | +77.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 78.3M 0 68.83M 64.07M 58.84M 110M 7.51B 112M 762M 297M 3.71B 294M 288M 12.81B | 67.56M 0 59.4M 55.29M 50.78M 95.35M 6.48B 96.6M 657M 257M 3.2B 254M 248M 11.06B |
| Net income | 15.72M 0 13.82M 12.87M 11.82M 22.19M 1.51B 22.48M 153M 59.73M 745M 59.02M 57.75M 2.57B | 4.07M 0 3.58M 3.33M 3.06M 5.75M 391M 5.82M 39.62M 15.48M 193M 15.29M 14.96M 667M |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
